Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT06200181
PHASE3
Effect of Olanzapine on Opioid Craving and Misuse Among Patients Receiving Opioids for Cancer-related Pain: A Pilot Double-Blind, Randomized Control Trial
Sponsor: M.D. Anderson Cancer Center
View on ClinicalTrials.gov
Summary
To learn about the effectiveness of taking the antipsychotic medication olanzapine to help lower opioid craving.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
87
Start Date
2024-04-02
Completion Date
2026-11-01
Last Updated
2026-02-13
Healthy Volunteers
No
Conditions
Interventions
DRUG
Olanzapine
Given by PO
DRUG
Olanzapine
Given by PO
DRUG
Placebo
Given by PO
Locations (1)
MD Anderson Cancer Center
Houston, Texas, United States